Expert neurologist Dr Lewis discusses the effect CIDP can have on the quality of life of a patient with CIDP as well as the unmet needs of the disease.
This is a video synopsis/summary of a panel discussion involving Richard Lewis, MD.
This discussion centers on the significant impact of CIDP (chronic inflammatory demyelinating polyneuropathy) on patients' quality of life and functional abilities. The studies highlighted reveal a marked reduction in the quality of life for CIDP patients, with substantial functional disabilities. A considerable portion, around 20 to 30% of patients, requires wheelchairs, while others rely on various aids like ankle foot orthoses, canes, and walkers. Hand dysfunction poses challenges for daily activities, particularly in the age of widespread computer use.
The emotional toll of dealing with a chronic disease adds another layer of difficulty for individuals affected by CIDP. The speaker emphasizes the multifaceted impact of the disorder, extending beyond neuropathic aspects to become a major life struggle.
Addressing unmet needs, the speaker stresses the necessity for a better understanding of CIDP's pathophysiology and the differences between its variants. Additionally, the challenges of addressing long-term complications, such as axonal destruction or degeneration, are highlighted. The search for treatments with limited risks, ease of use, and high benefits is acknowledged, while recognizing the inherent complexities and potential risks associated with immunosuppressants.
Video synopsis is AI-generated and reviewed by NeurologyLive editorial staff.